AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 187 filers reported holding AMAG PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,999,000 | +13.5% | 212,667 | -7.7% | 0.00% | 0.0% |
| Q2 2020 | $1,762,000 | +21.9% | 230,329 | -1.5% | 0.00% | 0.0% |
| Q1 2020 | $1,446,000 | -51.1% | 233,855 | -3.8% | 0.00% | 0.0% |
| Q4 2019 | $2,958,000 | +12.6% | 243,065 | +6.9% | 0.00% | 0.0% |
| Q3 2019 | $2,628,000 | +9.6% | 227,480 | -5.2% | 0.00% | 0.0% |
| Q2 2019 | $2,397,000 | -20.0% | 239,935 | +3.1% | 0.00% | 0.0% |
| Q1 2019 | $2,996,000 | -7.2% | 232,710 | +9.5% | 0.00% | -50.0% |
| Q4 2018 | $3,230,000 | -24.5% | 212,615 | -0.6% | 0.00% | +100.0% |
| Q3 2018 | $4,279,000 | -11.4% | 213,950 | -13.6% | 0.00% | -50.0% |
| Q2 2018 | $4,830,000 | +20.0% | 247,740 | +24.0% | 0.00% | 0.0% |
| Q1 2018 | $4,026,000 | +66.8% | 199,795 | +9.7% | 0.00% | +100.0% |
| Q4 2017 | $2,413,000 | -30.0% | 182,135 | -2.0% | 0.00% | -50.0% |
| Q3 2017 | $3,446,000 | +1.0% | 185,762 | +0.2% | 0.00% | 0.0% |
| Q2 2017 | $3,412,000 | -17.7% | 185,457 | +0.8% | 0.00% | 0.0% |
| Q1 2017 | $4,148,000 | -33.0% | 183,936 | +3.5% | 0.00% | -33.3% |
| Q4 2016 | $6,191,000 | +44.8% | 177,744 | +1.9% | 0.00% | +50.0% |
| Q3 2016 | $4,276,000 | -33.9% | 174,507 | -35.5% | 0.00% | -50.0% |
| Q2 2016 | $6,467,000 | -32.1% | 270,405 | -33.6% | 0.00% | -33.3% |
| Q1 2016 | $9,524,000 | +89.2% | 406,962 | +144.0% | 0.01% | +100.0% |
| Q4 2015 | $5,035,000 | -74.3% | 166,784 | -66.1% | 0.00% | -75.0% |
| Q3 2015 | $19,556,000 | +57.3% | 492,257 | +173.4% | 0.01% | +71.4% |
| Q2 2015 | $12,435,000 | +161.9% | 180,057 | +107.3% | 0.01% | +133.3% |
| Q1 2015 | $4,748,000 | +113.9% | 86,862 | +66.8% | 0.00% | +200.0% |
| Q4 2014 | $2,220,000 | +88.1% | 52,078 | +40.9% | 0.00% | 0.0% |
| Q3 2014 | $1,180,000 | +117900.0% | 36,953 | +123076.7% | 0.00% | – |
| Q2 2014 | $1,000 | -96.6% | 30 | -97.8% | 0.00% | – |
| Q3 2013 | $29,000 | -3.3% | 1,345 | 0.0% | 0.00% | – |
| Q2 2013 | $30,000 | – | 1,345 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 520,000 | $15,699,000 | 7.39% |
| Palo Alto Investors LP | 2,835,792 | $85,613,000 | 4.76% |
| Opaleye Management Inc. | 150,000 | $4,529,000 | 1.89% |
| Engaged Capital LLC | 61,425 | $1,854,000 | 1.15% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 91,400 | $2,759,000 | 1.14% |
| Endurant Capital Management LP | 111,180 | $3,357,000 | 1.12% |
| AlphaOne Investment Services, LLC | 86,817 | $2,621,000 | 0.94% |
| ASHFORD CAPITAL MANAGEMENT INC | 127,625 | $3,853,000 | 0.91% |
| ARDSLEY ADVISORY PARTNERS LP | 205,000 | $6,189,000 | 0.81% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 685,000 | $20,680,000 | 0.62% |